The PHQ-9 is the most widely-used brief depression screening tool in primary care, mental health, and research settings. Developed in 1999 by Kroenke, Spitzer, and Williams, it has been validated in over 100,000 patients across dozens of languages and demographic groups. Understanding what it does and does not measure is essential to using it well.

What the PHQ-9 Measures

The nine items of the PHQ-9 correspond directly to the nine symptoms of major depressive disorder from the DSM. Each item asks how often you've experienced that symptom in the past two weeks, scored 0 (not at all) to 3 (nearly every day). Total scores range from 0 to 27. The instrument was designed to be brief enough to fit into routine primary care visits while still capturing the full diagnostic symptom set. Importantly, the PHQ-9 measures CURRENT symptoms, not historical episodes — a person with prior depression who is currently well will score low; someone with new-onset depression will score high. The two-week window aligns with DSM diagnostic criteria for major depression.

Interpreting Scores

Score thresholds map to severity bands with substantial clinical validation. 0–4 is minimal symptoms — typical of healthy adults. 5–9 is mild depression — significant but often manageable with lifestyle changes, watchful waiting, or brief counseling. 10–14 is moderate depression — generally warrants professional treatment, often with therapy, medication evaluation, or both. 15–19 is moderately severe — typically requires structured treatment. 20–27 is severe depression — usually warrants medication evaluation plus intensive therapy, sometimes including consideration of higher levels of care. The cutoff of 10 has 88% sensitivity and 88% specificity for major depressive disorder against structured clinical interviews. A score under 10 doesn't rule out depression entirely, especially if symptoms are highly disruptive; a score over 10 strongly suggests clinical evaluation.

The Critical Role of Question 9

Question 9 asks about thoughts of self-harm or being better off dead. ANY positive response on Q9 (a score of 1, 2, or 3) warrants immediate clinical attention regardless of the total PHQ-9 score. Suicidal ideation is a separate clinical concern from depression severity — a person can have a low total score but elevated Q9, and that combination still requires intervention. Clinical protocols mandate same-day or next-day clinical contact for any positive Q9. If you score positive on Q9, contact the 988 Suicide and Crisis Lifeline (call or text), go to an emergency room, or contact a mental health professional immediately. Mental health crises are medical emergencies and deserve immediate response.

Limitations and Appropriate Use

The PHQ-9 is a screening tool, not a diagnostic instrument. Several conditions produce elevated PHQ-9 scores without major depression: bipolar disorder (depressive phase), grief reactions, certain medical conditions (hypothyroidism, anemia, chronic pain), substance use, side effects of medications, and acute stress reactions. A high score should prompt clinical evaluation, not self-diagnosis. The instrument also has known limitations in specific populations: post-partum women (PHQ-9 may underestimate severity), older adults (somatic symptoms overlap with normal aging), and adolescents (different version, PHQ-A, is preferred under age 18). Use the PHQ-9 alongside professional assessment, not as a replacement for it. If results concern you, talk to a healthcare provider.